Parkinson's Disease & Ginger: α-Synuclein, NLRP3, Dopamine and Gut-Brain Axis | INTI Belgium

INTI — Organic Ginger, Turmeric & Lemon Shot

INTI — Organic Ginger, Turmeric & Lemon Shot

⭐ 4.8/5 · 12,000+ orders · 50 organic stores 🇧🇪 · no added sugar

🛒 I discover INTI — less than €1/day
⚠️ Direct answer — Disease of ginger and Parkinson's & Ginger :
Parkinson's disease (PD) involves pathological aggregation of α-synuclein (Lewy bodies) in the substantia nigra → microglial NLRP3 activation → IL-1β/IL-18 → NF-κB nigral → progressive dopaminergic neuronal death. The Braak hypothesis (2003) proposes that PD begins in the intestine (myenteric plexus, vagus nerve) before progressing to the brain — the ginger constipation precedes motor symptoms by 10-20 years. 6-Gingerol inhibits microglial NLRP3, reduces α-synuclein aggregation in vitro, and protects dopamine neurons. Intestinal dysbiosis (↑ Pathological Akkermansia in PD, ↓ Prevotella) is a target microbiome. INTI Elixir: 1.19g of sugar per 100ml — the opposite of neuroinflammatory sugar. ⚠️ Never change levodopa or other antiparkinsonian treatments without the neurologist.

Parkinson’s: neuroinflammation cascade and gut-brain axis

PD is the 2nd neurodegenerative disease (after ginger and Alzheimer's), affecting 1% of those >60 years old (Belgium: ~30,000 patients). Key mechanisms:

  • Pathological α-Synuclein : misfolding → oligomers → fibrils → Lewy bodies. α-syn activates microglial TLR2/TLR4 → NF-κB → nigral TNF-α/IL-1β/IL-6 → dopaminergic neurotoxicity. Vicious neuroinflammation-neurodegeneration cycle.
  • NLRP3 microglial inflammasome : α-syn aggregates → NLRP3 activation → IL-1β/IL-18 → neuronal pyroptosis → pathology propagation (Prion-like spreading). NLRP3 inhibition = major therapeutic target MP.
  • Gut-brain axis (Braak hypothesis) : α-synuclein can initiate in the myenteric plexus (enteric nervous system) → retrograde propagation via vagus nerve → brainstem → substantia nigra. Prodromal signatures: constipation (87% MP), anosmia, REM sleep behavior disorder.
  • MP intestinal dysbiosis : ↓ Prevotella copri (butyrate producer), ↑ Akkermansia (paradoxical dual role in PD — certain pro-inflammatory strains), ↑ Enterococcus. Bacterial LPS → Nigral TLR4/NF-κB via vagus nerve. Study (Univ. Alabama): MP microbiome transplantation → germ-free mice → parkinsonian phenotype.
  • Dopamine and NF-κB : Activated nigral NF-κB inhibits tyrosine hydroxylase (TH) — rate-limiting enzyme dopamine synthesis. Result: dopamine ↓ → bradykinesia, rigidity, tremors.

6-Gingerol & Parkinson’s Neuroprotection

Molecular target Ginger action Parkinson’s Relevance
microglial NLRP3 6-gingerol → NLRP3 ↓ (inhibits assembly) IL-1β/IL-18 ↓, pyroptosis ↓
α-Synuclein aggregation Polyphenols → oligomers ↓ in vitro Lewy bodies training ↓
Nigral NF-κB IKKβ ↓ → TH expression ↑ Dopamine synthesis ↑ relative
Neuronal Nrf2/HO-1 Nrf2 activation → neuronal antioxidant ginger stress nigral oxidative ↓
Gut-vagus-brain axis Microbiome modulation → LPS ↓ TLR4/NF-κB nigral via wave ↓
Prodrome constipation Prokinetic 5-HT₄ (ginger) Intestinal transit ↑ (early symptom)
⚠️ CRITICAL MEDICAL WARNING — Parkinson’s disease:
  • Levodopa/carbidopa (Sinemet, Madopar) — Ginger can theoretically influence gastric motility (acceleration of emptying → modified levodopa absorption). Space INTI by 30-60 min between levodopa doses. Consult the neurologist.
  • MAOI-B (selegiline, rasagiline) — Ginger: no documented tyramine interaction (low content). Theoretical caution via CYP2D6 — consult.
  • Dopamine agonists (pramipexole, rotigotine) — No known interaction. Be careful with orthostatic hypotension (ginger can influence BP).
  • Never interrupt antiparkinsonian treatments — Sudden cessation of levodopa → neuroleptic malignant syndrome. Always gradual under neurological supervision.
  • Dysphagia — 80% of advanced PD have swallowing disorders. INTI must be administered safely (concentrated liquid to be diluted).

INTI vs. GIMBER — Parkinson's disease

MP criterion INTI Elixir GIMBER
Sugar (neuroinflammation) 1.19g/100ml ~35g/100ml → neuronal NLRP3 ↑
Gut microbiome Polyphenols → LPS ↓, transit ↑ Sugar → dysbiosis → nigral TLR4 ↑
microglial NLRP3 6-gingerol → NLRP3 assembly ↓ 35g sugar → NLRP3 fuel
Prodrome constipation 5-HT₄ prokinetic → transit ↑ Sugar → dysbiosis → constipation ↑
α-Synuclein aggregation Polyphenols → oligomers ↓ AGE (sugar) → α-syn glycation ↑
FAQ — Parkinson's Disease & Ginger (10 questions)

Q1: Can ginger slow the progression of Parkinson's?
Preclinical studies show that 6-gingerol inhibits microglial NLRP3, reduces α-synuclein aggregation, and protects dopamine neurons. No MP-specific randomized clinical trial is yet available. Ginger is a neuroprotective nutritional adjuvant, not a disease-modifying treatment.

Q2: The Braak hypothesis — what is it?
Heiko Braak (2003) proposed that PD begins in the intestine (myenteric plexus) and progresses retrogradely via the vagus nerve to the brain. This explains why constipation precedes tremors by 10-20 years. The gut-brain axis is therefore central in PD.

Q3: Why is sugar particularly dangerous in PD?
Sugar → AGE (Advanced Glycation End-products) → glycation of α-synuclein → accelerated aggregation. Additionally, sugar → NLRP3 activation → IL-1β → neurotoxicity. GIMBER at 35g sugar/100ml is an “NLRP3 fuel” in MP.

Q4: How does ginger interact with levodopa?
Ginger accelerates the ginger bloating-irritable colon">gastric emptying (prokinetic) → can modify the kinetics of absorption of levodopa. Space INTI by 30-60 min between Sinemet/Madopar doses. Always validate with the treating neurologist.

Q5: Can Parkinson's constipation be helped by ginger?
Yes — ginger (6-gingerol/shogaol) activates myenteric 5-HT₄ receptors → prokinetic → transit improvement. MP constipation precedes motor symptoms and aggravates dysbiosis → nigral TLR4. Targeting constipation is an indirect neuroprotective strategy.

Q6: Parkinson's anosmia — can ginger help?
MP anosmia (olfactory bulb—Braak stage 1) results from α-syn accumulation in olfactory neurons. Ginger (α-syn aggregation ↓, NLRP3 ↓) is theoretically beneficial but no specific olfactory assays available.

Q7: Parkinson's with Dementia (PDD) — Is NRTI appropriate?
PDD (30-80% of advanced PD) involves hippocampal NF-κB and neocortical α-syn extension. INTI (6-gingerol BBB partial crossing, anti-NLRP3) can be an adjuvant. Dysphagia to assess — NRTI diluted in water.

Q8: Deep Brain Stimulation (DBS) — interactions with ginger?
DBS (subthalamic nucleus) is an advanced MP surgical treatment. No known interactions with ginger. Continue NRTI under usual neurosurgical supervision.

Q9: Parkinsons resting tremor vs. essential tremor — difference?
Essential tremor (ET) is different from PD: symmetrical, action, no Lewy body. 6-gingerol (central anti-NF-κB) may be relevant in both contexts but for different mechanisms.

Q10: Where to find INTI in Belgium for a Parkinson’s patient?
INTI available on inti-drink.com and Belgian pharmacies/health stores. 1.19g sugar, without liver-protect-gingembre-lendemain-fete-2026">alcohol, without sweeteners — suitable for PD patients (favorable metabolic profile, mild prokinetic). Dysphagia: dilute in lukewarm water.

🧠 INTI vs. GIMBER — Parkinson's disease

GIMBER: 35g sugar/100ml → AGE-α-syn glycation ↑ + NLRP3 fuel + dysbiosis → TLR4 nigral ↑
NRTI: 1.19g of sugar per 100ml → NLRP3 ↓ + α-syn aggregation ↓ + protected gut-brain axis

⚠️ Always under the supervision of the neurologist — Never modify levodopa

Discover INTI — 1.19g sugar

Related articles

To learn more about the subject, also read:

Useful INTI pages

To go further:

Have you read this far? Get into practice 👇

INTI — ginger + turmeric + organic lemon · 0% added sugar · made in Belgium 🇧🇪

INTI shot organic ginger turmeric lemon

Reader code -15%: INTI15

🛒 Discover INTI — from €22.90

⭐ 4.8/5 · 12,000+ orders · 50 organic stores

Back to blog